NCT03929991 (MACSI) is a clinical trial of Observational in Infection, sponsored by Doctors with Africa - CUAMM.

Who is sponsoring NCT03929991?

NCT03929991 is sponsored by Doctors with Africa - CUAMM.

What drugs are being tested in NCT03929991?

Interventions in NCT03929991: Observational.

What condition does NCT03929991 study?

NCT03929991 studies Infection, Cesarean Section Complications, Site Infection, Maternal Death.

Is NCT03929991 still recruiting?

NCT03929991 is currently status unknown. Last updated 30 April 2019.

Last reviewed 2019-04-30 · How we verify

NCT03929991: MACSI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maternal Cesarian Section Infection (MACSI) in Sierra Leone

Status unknown Last updated 30 April 2019

What this trial tests

trial testing Observational in Infection in 1,000 participants. Status unknown.

Timeline

1 May 2018

Primary endpoint
1 October 2019

1 May 2020

Quick facts

Lead sponsor	Doctors with Africa - CUAMM
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 May 2018
Primary completion	1 October 2019
Estimated completion	1 May 2020
Sites	1 location across Sierra Leone

Drugs / interventions tested

Observational — full drug profile →

Conditions studied

Infection — all drugs for Infection →
Cesarean Section Complications — all drugs for Cesarean Section Complications →
Site Infection — all drugs for Site Infection →
Maternal Death — all drugs for Maternal Death →

Sponsor

Doctors with Africa - CUAMM

Who can join

Eligibility, female only, with Infection or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound infection. Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. The prevention of these infections is complex and requires the integration of a range of preventive measures before, during, and after surgery. The aim of the proposed project is to determine the risk factors of Surgical Site Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the predictors of a negative outcome in women with post-CS SSI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Maternal caesarean section infection (MACSI) in Sierra Leone: a case-control study.
Di Gennaro F, Marotta C, Pisani L, Veronese N, et al · · 2020 · cited 37× · PMID 32102721 · DOI 10.1017/s0950268820000370

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

NCT07356700 — Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong · not yet recruiting
NCT07381751 — Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease · not yet recruiting
NCT07347574 — NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK · not yet recruiting
NCT07338968 — A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma · not yet recruiting
NCT06792994 — A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients Wi · not yet recruiting

Other recruiting trials for Infection

Currently open trials in the same condition.

NCT07358117 — Viral Infections of the Central Nervous System: Diagnosis and Clinical Outcome · active not recruiting
NCT07110636 — Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients · NA · recruiting
NCT06806709 — Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) · NA · recruiting
NCT06974162 — Metagenomics for Ocular Inflammation · recruiting
NCT07370948 — Study of the Antibiotic-resistance Profile of Enterobacterales Isolated From Rectal Mucosal Buffer of PrEP Subjects · recruiting

Other Doctors with Africa - CUAMM trials

Trials by the same sponsor.

NCT06219109 — Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia · unknown
NCT05348746 — ERASE - Impact of COVID-19 on Malaria Control · unknown
NCT03856307 — Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis · completed
NCT04121234 — Critically-Ill Women Admitted to an Obstetric High Dependency Unit in a Resource-Limited Setting · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03929991 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Doctors with Africa - CUAMM
Last refreshed: 30 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03929991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing